Fidelio Capital acquires Premune’s shares in Nextmune

FidelioCapitalacquiresPremune’ssharesinNextmune

Copy link

We are pleased to announce that, effective 24 November 2020, Fidelio Capital AB (“Fidelio”) has completed the acquisition of Premune AB’s (“Premune”) shares in Nextmune.

Through the transaction, Fidelio will increase its ownership in Nextmune and become the majority owner. Nextmune is a leading company within specialty pharmaceuticals for companion animals with sales in over 75 markets worldwide.

With Fidelio as the majority owner, Nextmune will have the support and resources to continue to invest in innovation and R&D and to broaden its product portfolio. The transaction will not lead to any operational changes in the company, which will continue to run in the same way as today.

Fidelio looks forward to continuing to support Nextmune on its journey to improve the quality of life for companion animals around the world.

Morenews

News

2025-07-01

Fidelio invests in Alphalyse to support global growth in biologic drug analytics

Fidelio has acquired a majority stake in Alphalyse, a Danish specialist contract research organisation (CRO) focused on liquid-chromatography mass-spectrometry (LC-MS) based analytics.

News

2025-06-26

Odevo expands to southern Europe and Latin America as Portik joins the group

Odevo continues its international expansion with entry into Spain, Italy, Mexico, and Portugal as Portik is added to the group. Portik is a fast-growing company that has built a strong presence across fragmented markets by consistently delivering value to homeowners and residents.

News

2025-06-18

KEYTO enters the UK

KEYTO Group expands to the UK through GreenThumb – the country’s largest lawn care provider – marking KEYTO’s first step outside Sweden.